808 filings
Page 11 of 41
8-K
47ore nxusr7rr
11 Sep 17
Peregrine Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2018 and Recent Developments
12:00am
DEFA14A
8rkg8cy5
11 Sep 17
Additional proxy soliciting materials
12:00am
UPLOAD
ml1q 2ve4
6 Sep 17
Letter from SEC
12:00am
8-K
2bk9720 lvntgps
5 Sep 17
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible
12:00am
4
bpt8tpi4z5h3gb
29 Aug 17
PEREGRINE PHARMACEUTICALS / ERIC S SWARTZ ownership change
12:00am
PREC14A
jysgzudgnbalm ewdcb
29 Aug 17
Preliminary proxy with contested solicitation
12:00am
4
34n2dr9rn
29 Aug 17
PEREGRINE PHARMACEUTICALS / CARLTON M JOHNSON ownership change
12:00am
4
ppuar96zx7w 4x
29 Aug 17
PEREGRINE PHARMACEUTICALS / DAVID POHL ownership change
12:00am
DFAN14A
xi7zwghy62t6k1e5zk3
14 Aug 17
Additional proxy materials by non-management
12:00am
SC 13G/A
zziw n1uw
14 Aug 17
Peregrine Pharmaceuticals Inc
12:00am
8-K
d7ixyj8j
11 Aug 17
Peregrine Announces Measures to Reduce Costs, Facilitate Profitability and Strengthen its Operations
12:00am
DEFA14A
2lwr09
11 Aug 17
Additional proxy soliciting materials
12:00am
DEFA14A
j4owet
31 Jul 17
Additional proxy soliciting materials
12:00am
8-K
s9ssq2e yj
25 Jul 17
Other Events
12:00am
DEFA14A
siz668dia2d
21 Jul 17
Additional proxy soliciting materials
12:00am
SC 13G
gf9dpe mzz
20 Jul 17
Peregrine Pharmaceuticals Inc
12:00am
DFAN14A
yat7n7j2o7jo
20 Jul 17
Additional proxy materials by non-management
12:00am
SC 13D/A
8zvykets3r0 d6
14 Jul 17
Peregrine Pharmaceuticals Inc
12:00am